Proceedings From the Global Cardio-Oncology Summit

Daniel J. Lenihan, MD; Michael G. Fradley, MD; Susan Dent, MD; Christine Brezden-Masley, MD, PhD; Joseph Carver, MD; Roberto Kalil Filho, MD, PhD; Tomas G. Neilan, MD, MPH; Anne Blaes, MD; Chiara Melloni, MD, MHS; Joerg Herrmann, MD; Saro Armenian, DO, MPH; Paaladinesh Thavendiranathan, MD, SM; Gregory T. Armstrong, MD, MSCE; Bonnie Ky, MD, MSCE; Ludhmila Hajjar, MD

JACC. CardioOncology (Dec 2019)

Proceedings From the Global Cardio-Oncology Summit

Daniel J. Lenihan, MD,
Michael G. Fradley, MD,
Susan Dent, MD,
Christine Brezden-Masley, MD, PhD,
Joseph Carver, MD,
Roberto Kalil Filho, MD, PhD,
Tomas G. Neilan, MD, MPH,
Anne Blaes, MD,
Chiara Melloni, MD, MHS,
Joerg Herrmann, MD,
Saro Armenian, DO, MPH,
Paaladinesh Thavendiranathan, MD, SM,
Gregory T. Armstrong, MD, MSCE,
Bonnie Ky, MD, MSCE,
Ludhmila Hajjar, MD

Affiliations

Daniel J. Lenihan, MD: Cardio-Oncology Center of Excellence, Cardiovascular Division, Department of Internal Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri; Address for correspondence: Dr. Daniel J. Lenihan, Cardiovascular Division, Washington University in St. Louis, 660 South Euclid Avenue, Campus Box 8086, St Louis, Missouri 63110.
Michael G. Fradley, MD: Cardio-Oncology Program, Moffitt Cancer Center, University of South Florida, Tampa, Florida
Susan Dent, MD: Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina
Christine Brezden-Masley, MD, PhD: Mount Sinai Hospital, University of Toronto, Toronto, Canada
Joseph Carver, MD: Cardio-Oncology Center of Excellence at the Abramson Cancer Center, Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Roberto Kalil Filho, MD, PhD: Cardio-Oncology Program, Department of Cardiopneumology, Cancer Institute and Heart Institute, University of São Paulo, Brazil
Tomas G. Neilan, MD, MPH: Cardio-Oncology Program, Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
Anne Blaes, MD: Division of Hematology/Oncology, University of Minnesota, Minneapolis, Minnesota
Chiara Melloni, MD, MHS: Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina
Joerg Herrmann, MD: Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota
Saro Armenian, DO, MPH: City of Hope Comprehensive Cancer Center, Duarte, California
Paaladinesh Thavendiranathan, MD, SM: Division of Cardiology, Peter Munk Cardiac Centre, Ted Rogers Program in Cardiotoxicity Prevention, University Health Network, University of Toronto, Toronto, Canada
Gregory T. Armstrong, MD, MSCE: Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, Memphis, Tennessee
Bonnie Ky, MD, MSCE: Cardio-Oncology Center of Excellence at the Abramson Cancer Center, Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Ludhmila Hajjar, MD: Cardio-Oncology Program, Department of Cardiopneumology, Cancer Institute and Heart Institute, University of São Paulo, Brazil

Journal volume & issue: Vol. 1, no. 2
pp. 256 – 272

Abstract

Read online

The discipline of cardio-oncology has expanded at a remarkable pace. Recent developments and challenges to clinicians who practice cardio-oncology were presented at the Global Cardio-Oncology Summit on October 3 to 4, 2019, in São Paulo, Brazil. Here, we present the top 10 priorities for our field that were discussed at the meeting, and also detail a potential path forward to address these challenges. Defining robust predictors of cardiotoxicity, clarifying the role of cardioprotection, managing and preventing thromboembolism, improving hematopoietic stem cell transplant outcomes, personalizing cardiac interventions, building the cardio-oncology community, detecting and treating cardiovascular events associated with immunotherapy, understanding tyrosine kinase inhibitor cardiotoxicity, and enhancing survivorship care are all priorities for the field. The path forward requires a commitment to research, education, and excellence in clinical care to improve our patients' lives.

Published in JACC. CardioOncology

ISSN: 2666-0873 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system; Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.journals.elsevier.com/jacc-cardiooncology

About the journal

Abstract

Keywords